OR WAIT null SECS
Pharmaceutical Technology spoke with Frank Generotzky, plant manager for Baxter BioPharma Solutions’ Halle, Germany facility, about operational excellence at the site.
The Baxter BioPharma Solutions (BPS) Oncology manufacturing expansion project at its Halle, Germany location was the winner of the Operational Excellence category of the 2016 International Society of Pharmaceutical Engineering (ISPE) Facility of the Year Awards (1). The company applied lean manufacturing principles in designing the expanded facility. The flexible design with adaptable equipment gave the company the ability to have rapid changeover to manufacture a wide variety of liquid formulations. Pharmaceutical Technology spoke with Frank Generotzky, plant manager for Baxter BioPharma Solutions’ Halle, Germany facility, about operational excellence at the site.
PharmTech: How would you define manufacturing excellence or operational excellence for the pharma industry, and what are the keys to achieving it?
Generotzky (Baxter): The pursuit of operational excellence is an ongoing goal driving improvement. Operational excellence leads to continuous improvement to increase efficiency as well as capacity while maintaining high quality and client satisfaction. Some examples of methods include:
PharmTech: What programs have you found to be successful?
Generotzky (Baxter): It is important to implement programs where all employees are involved (from operator to manager) to enhance success. Creating an uplifting experience for the employees by implementing programs internally such as 5S and process visualization helps to pave the way for the implementation of more complex systems such as operational equipment effectiveness or SixSigma. At the end of the day, success is dependent on having the necessary tools (e.g., a value stream map being supported, for example, by failure mode and effects analyses, fishbone diagrams, and standard control charts). Additionally, statistical tools should be leveraged in order to determine variation signals early in the process so that countermeasures can be implemented in a timely manner.
PharmTech: What aspects in particular of lean manufacturing have been most beneficial?
Generotzky (Baxter): Applying 5S in manufacturing areas and increasing the time that managers are on the floor (‘Gemba Time’) can help ensure a high degree of standardization and discipline. Continuous measurement of process parameters with standard control charts and statistical evaluation leads to continuous improvement of yield and reduction of process deviations.
PharmTech: What is the importance of process standardization?
Generotzky (Baxter): A high degree of standardization ensures low variability between batches, reduces stock and work in progress, and helps to enhance planning security. Standardization leads to stable and predictable processes, which are the basis for true efficiency enhancements.
PharmTech: What is flexible design and how does this lead to operational excellence?
Generotzky (Baxter): Today’s products have become more complex to manufacture (e.g., nanotech products) and smaller from a volume perspective, and additionally there is the demand to simplify the handling infrastructure to be as efficient as possible. In many cases, the same manufacturing rooms are used for different process set-ups. The result is that manufacturing departments need to change process design between manufacturing of batches quickly and efficiently. Standardized modular equipment and process design is important to minimize set-up and turnover times to manufacture efficiently and remain cost competitive. Therefore, we define flexible design as one important component in our operational excellence program.
Vol. 41, No. 3
Page: 22, sidebar to J. Markarian, "Achieving Manufacturing Excellence," Pharmaceutical Technology 41 (3) 2017